Adjacent, every mention

Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings May 22, 2023 · 11 mentions

• ▶ 4:56 Nico Wittenborn And then in 2019, I decided to leave and start adjacent, which is where I'm now at a firm that I founded and which is an early stage fund that is investing across both Europe and the U.S.
• ▶ 5:18 Harry Stebbings What's one takeaway from each that's impacted how you think and taken with you to adjacent?
• ▶ 15:07 Nico Wittenborn The way that we steer them, and this now touches CAC, is usually we always, the companies I work with, this is the adjacent companies that I'm talking about, we steer acquisition so that we recover the CAC with the first year, ok?
• ▶ 21:37 Harry Stebbings And then I do want to move to adjacent, but when we look at kind of the, the channels at our disposal to acquire customers, the thing that also worries me is they're so volatile in terms of our control of them.
• ▶ 43:34 Nico Wittenborn This is the first time I talk about adjacent publicly for you. 2 times in the scene
• ▶ 55:10 Nico Wittenborn Yeah, so this is, I mean, it's one of the reasons the firm is called, and we were three questions deep here, so I might have to go back into the, the former questions after, but the, so the adjacent, um, I, I call it the firm adjacent… 2 times in the scene
• ▶ 59:23 Nico Wittenborn Um, but I, the way I think about it from an adjacent perspective is we're going to have, um, companies that are already consumer subscription companies that are implementing this to make their products even more sticky, more functional and…
• ▶ 1:06:51 Harry Stebbings What's the hardest thing with adjacent for you today, Nico?
• ▶ 1:27:31 Harry Stebbings So the next five years for you and adjacent.